why is there no news from the hairloss congress? or was there nothing worth posting whatsoever?
Lack of news from hairloss congress?
Collapse
X
-
Here's some news. Look like Replicel is going to happen. Great interview! Thanks Spencer!
Comment
-
Here's some news. Look like Replicel is going to happen. Great interview! Thanks Spencer!
https://www.baldtruthtalk.com/thread...ecord-Straight
I really hope there is better news than that!!Comment
-
CB and SM are both finishing up their phase II trials, so expect news in Q1 2016 from those two! Lots of updates coming very soon, I wouldn't worry about the congress not having much.Comment
-
Comment
-
Nope, but Bim is pushing forward with their second Phase IIb trial(had good efficacy in first phase IIb, now testing at even higher dosage/different vehicle) which is a very good sign of them likely going to phase III just finding the perfect dose first.
on top of that Replicel is heading into the phase II Japan trials which means the product can launch into market after those are done.
basically we're no longer in the "5 years away" timeline, more like 2-3 years with many products getting closer.Comment
-
Nope, but Bim is pushing forward with their second Phase IIb trial(had good efficacy in first phase IIb, now testing at even higher dosage/different vehicle) which is a very good sign of them likely going to phase III just finding the perfect dose first.
on top of that Replicel is heading into the phase II Japan trials which means the product can launch into market after those are done.
basically we're no longer in the "5 years away" timeline, more like 2-3 years with many products getting closer.Comment
-
The problem with Histogen is that they never had the funding that many other companies have(BIM is backed by a multi-billion dollar allergans) and have struggled to garner any attention for funding the past few years. They had an interesting start but still haven't pushed forward, although they said this year they'd attempt to move forward with Japan trials at least, but I'm not sure they have the funding yet.
either way they shouldn't be high on your radar, I think the product was effective but nothing spectacularComment
-
The problem with Histogen is that they never had the funding that many other companies have(BIM is backed by a multi-billion dollar allergans) and have struggled to garner any attention for funding the past few years. They had an interesting start but still haven't pushed forward, although they said this year they'd attempt to move forward with Japan trials at least, but I'm not sure they have the funding yet.
either way they shouldn't be high on your radar, I think the product was effective but nothing spectacularComment
-
The problem with Histogen is that they never had the funding that many other companies have(BIM is backed by a multi-billion dollar allergans) and have struggled to garner any attention for funding the past few years. They had an interesting start but still haven't pushed forward, although they said this year they'd attempt to move forward with Japan trials at least, but I'm not sure they have the funding yet.
either way they shouldn't be high on your radar, I think the product was effective but nothing spectacularComment
-
You'll want to check out: https://www.baldtruthtalk.com/thread...rview?p=223984Comment
Comment